From the medical point of view, inactivation of GSK-3β by LiCl alone [39] or in combination with HDACi [40] was found to be sufficient to inhibit growth in medullary thyroid cancer cells. This evidence concerns the gene GSK3B and medullary thyroid gland carcinoma.